BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 124 filers reported holding BLUEBIRD BIO INC in Q3 2014. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $30,150,000 | -12.9% | 1,000,000 | +25.0% | 1.04% | -14.8% |
| Q4 2020 | $34,616,000 | -70.8% | 800,000 | -63.6% | 1.22% | -61.2% |
| Q3 2020 | $118,690,000 | +52.5% | 2,200,000 | +72.5% | 3.13% | -29.7% |
| Q2 2020 | $77,826,000 | +207.2% | 1,275,000 | +94.1% | 4.45% | +168.3% |
| Q2 2014 | $25,337,000 | +57.6% | 656,900 | -7.1% | 1.66% | +31.7% |
| Q1 2014 | $16,075,000 | +270.3% | 706,900 | +241.7% | 1.26% | +229.0% |
| Q4 2013 | $4,341,000 | +7.3% | 206,900 | +37.9% | 0.38% | -9.7% |
| Q3 2013 | $4,044,000 | +8.0% | 150,000 | 0.0% | 0.42% | +10.1% |
| Q2 2013 | $3,745,000 | – | 150,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |